Praxis Precision Medicines reports positive trial results for epilepsy drug
Go back to Praxis Precision Medicines reports positive trial results for epilepsy drug| (NASDAQ: PRAX) | Delayed: 247.09 +6.43 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.66 | 52 Week High | $ | |||
| Open | $241.01 | 52 Week Low | $ | |||
| Day High | $247.86 | P/E | N/A | |||
| Day Low | $239.41 | EPS | $ | |||
| Volume | 107,557 | |||||

